We are live on ! Find out more
IMDZ

Immune Design Corp.
IMDZ

Delisted

IMDZ was delisted on the 1st of April, 2019.

Back to rankings

0 hedge funds and large institutions have $0 invested in Immune Design Corp. in 2019 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 66 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 68 → 0 (-68)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

100% less capital invested

Capital invested by funds: $165M → $0 (-$165M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 66

Holders
–
Holders Change
-68
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
66
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
PS
Peter Svennilson
-$38.9M
2
AAM
Alpine Associates Management
Florida
-$14M
3
BlackRock
BlackRock
New York
-$13.1M
4
TAL
TIG Advisors LLC
New York
-$11.8M
5
Vanguard Group
Vanguard Group
Pennsylvania
-$8.9M
Name Holding Trade Value Shares
Change 		Change in
Stake
HCMT
26
Highland Capital Management (Texas)
Texas
– -$1.11M -190,000 Closed
Bank of New York Mellon
27
Bank of New York Mellon
New York
– -$1.06M -182,103 Closed
Deutsche Bank
28
Deutsche Bank
Germany
– -$1.03M -176,554 Closed
KPF
29
K2 Principal Fund
Ontario, Canada
– -$926K -158,255 Closed
LIM
30
Longfellow Investment Management
Massachusetts
– -$758K -129,630 Closed
HM
31
Harvest Management
New York
– -$527K -90,000 Closed
Charles Schwab
32
Charles Schwab
California
– -$474K -80,936 Closed
California State Teachers Retirement System (CalSTRS)
33
California State Teachers Retirement System (CalSTRS)
California
– -$305K -52,212 Closed
RhumbLine Advisers
34
RhumbLine Advisers
Massachusetts
– -$277K -47,386 Closed
GI
35
GAMCO Investors
Connecticut
– -$268K -45,885 Closed
State of Wisconsin Investment Board
36
State of Wisconsin Investment Board
Wisconsin
– -$267K -45,700 Closed
BCM
37
Bridgeway Capital Management
Texas
– -$248K -42,400 Closed
PP
38
Paloma Partners
Connecticut
– -$233K -39,802 Closed
Goldman Sachs
39
Goldman Sachs
New York
– -$208K -35,567 Closed
PCM
40
Prelude Capital Management
New York
– -$193K -32,983 Closed
MS
41
Maven Securities
Jersey
– -$175K -30,000 Closed
VF
42
Virtu Financial
New York
– -$172K -29,460 Closed
PPA
43
Parametric Portfolio Associates
Washington
– -$166K -28,419 Closed
BFM
44
Boothbay Fund Management
New York
– -$159K -27,122 Closed
Manulife (Manufacturers Life Insurance)
45
Manulife (Manufacturers Life Insurance)
Ontario, Canada
– -$137K -23,468 Closed
Barclays
46
Barclays
United Kingdom
– -$136K -23,314 Closed
AIG
47
American International Group
New York
– -$126K -21,492 Closed
New York State Common Retirement Fund
48
New York State Common Retirement Fund
New York
– -$118K -20,100 Closed
Wells Fargo
49
Wells Fargo
California
– -$92K -15,652 Closed
CCM
50
Chicago Capital Management
Illinois
– -$69K -11,816 Closed
1
2
3

IMDZ Hedge Fund Activity: Q2 2019 in Review

0 of the 4,605 institutional investors tracked by Wall St. Rank reported a position in Immune Design Corp. (IMDZ) for Q2 2019, worth a combined $0 — down 100% from $165M a quarter earlier.

Sellers outnumbered buyers: 66 funds closed out of IMDZ and 0 opened new positions — a net loss of 66 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Peter Svennilson, exiting entirely with an estimated $38.9M sold.

  • 0 institutional investors held Immune Design Corp. (IMDZ) as of Q2 2019, down from 68 in Q1 2019.
  • Funds reported $0 of Immune Design Corp. stock for Q2 2019, down 100% quarter-over-quarter.
  • 0 funds opened new Immune Design Corp. positions in Q2 2019 and 66 closed out, a net change of -66 holders.
  • The largest Immune Design Corp. seller in Q2 2019 was Peter Svennilson, an estimated $38.9M sold.

Based on aggregated 13F filings for Q2 2019.